IRVINE, Calif., April 2, 2025 /PRNewswire/ — University Lab Partners (ULP) proudly announces the selection of nine cutting-edge MedTech companies for the inaugural cohort of the International Consortium for Research, Engineering, Acceleration of Technology Excellence (I-CREATE). I-CREATE serves as the BARDA Accelerator Network’s Medical Devices and Diagnostics Hub and is executed in partnership with CIMIT and Science Exchange.
“We are thrilled to welcome this exceptional group of companies, representing diverse and groundbreaking innovations,” said Sandra J. Miller, Executive Director of University Lab Partners. “We look forward to supporting them, alongside our partners, as they advance their technologies to address critical health security challenges.”
About I-CREATE and the 2025 Cohort
I-CREATE is one of five strategic BARDA Accelerator Network Hubs (BAN 2.0), focused on empowering innovative startups to accelerate the development, scalability, and commercialization of medical devices and diagnostics globally. The program emphasizes advancing innovative technology to develop medical countermeasures that address the public health and medical consequences of chemical, biological, radiological, and nuclear (CBRN) accidents, incidents and attacks, pandemic influenza, and emerging infectious diseases
Three companies will each receive up to $200,000 in non-dilutive funding, customized mentorship to fit their needs, and consulting over six months to support the development, evaluation, or validation of their diagnostic or medical device solution.
Six additional companies will participate in a six-month accelerator program featuring tailored workshops, advisory services, consulting, mentorship and compete for a prize of up to $50,000.
All nine companies will present their innovations to potential investors at the I-CREATE Virtual Showcase on May 20, 2025. For more information, please visit www.universitylabpartners.org/contact
This project has been supported in whole or in part with federal funds from the U.S. Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority (BARDA), under agreement number 75A50124C00007.
About I-CREATE
I-CREATE fosters groundbreaking innovation in the medical device and diagnostics sectors by serving as a bridge between startups and a network of investors, industry leaders, and experienced mentors. Through this collaboration, the program empowers entrepreneurs to navigate the complexities of development and commercialization, driving the advancement of transformative medical countermeasures that address critical health challenges and improve lives globally.
About University Lab Partners
University Lab Partners (ULP) is a premier nonprofit wet lab incubator located in Orange County, CA, with facilities in Irvine and Aliso Viejo. ULP provides state-of-the-art wet lab spaces and fosters a vibrant entrepreneurial community focused on life sciences. In addition to offering highly equipped facilities and peer-to-peer collaboration opportunities, ULP runs global accelerator programs and workforce development initiatives, empowering innovators and advancing the life sciences ecosystem worldwide. www.universitylabpartners.org
SOURCE University Lab Partners
NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…
AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…
Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…
Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…
Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…
Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…